Search

NeoGenomics Inc

Open

SectorGezondheidszorg

19.02 1.71

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

18.42

Max

19

Belangrijke statistieken

By Trading Economics

Inkomsten

19M

2.2M

Verkoop

15M

202M

EPS

-0.01

Winstmarge

1.11

Werknemers

2,500

EBITDA

19M

19M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

-2.95% downside

Dividenden

By Acuity

Volgende Winsten

27 okt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

783M

2.5B

Vorige openingsprijs

17.31

Vorige sluitingsprijs

19.02

Nieuwssentiment

By Acuity

87%

13%

310 / 339 Rangschikking in Healthcare

NeoGenomics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 sep 2026, 20:07 UTC

News

Neogenomics Inc shares fell sharply, declining since Monday's close, despite early session gains and interest in its strategic shift towards precision oncology.

21 sep 2026, 21:21 UTC

Neogenomics Inc is trading modestly lower in after-market hours, declining from an initial high despite being above its 20-day moving average.

17 sep 2026, 20:07 UTC

Correlated Moves

Neogenomics Inc is advancing, supported by gains in the ARK Genomic Revolution ETF and positive broader market trends, marking five consecutive sessions of gains.

15 sep 2026, 20:07 UTC

Neogenomics Inc's shares are higher today, reflecting a notable increase since Monday's close. The stock remains above its 20-day moving average.

14 sep 2026, 23:46 UTC

Neogenomics Inc shares are modestly higher in after-market trading, maintaining a position above its 20-day moving average and near the top of its one-month range.

11 sep 2026, 21:01 UTC

Neogenomics Inc shares declined in after-market trading, coinciding with a significant drop in the Michigan Consumer Sentiment Index. No specific company news was identified.

10 sep 2026, 20:07 UTC

Neogenomics Inc shares are lower today amid a broader market decline and rising Treasury yields, with no specific company news identified.

9 sep 2026, 20:07 UTC

Neogenomics Inc's shares are higher Wednesday, despite an earlier pullback. No specific company news was identified to explain the price movement.

8 sep 2026, 19:26 UTC

Neogenomics Inc shares are higher today, continuing gains since Friday. The stock remains above its 20-day moving average and within its one-month range.

4 sep 2026, 23:20 UTC

Neogenomics Inc shares are higher in after-market trading, reflecting strong performance since Friday's close and positioning above its 20-day moving average.

2 sep 2026, 20:08 UTC

Neogenomics Inc is lower in Wednesday's session, continuing a trend of four consecutive declines. No specific news was identified to explain the move.

1 sep 2026, 20:08 UTC

Neogenomics Inc shares are lower today, continuing a downward trend since Monday. No specific company news was identified to explain the decline.

31 aug 2026, 20:07 UTC

Social Media

Neogenomics Inc shares are lower amid rising interest rate hike expectations following recent economic commentary. Earlier, the stock rebounded from a session high.

28 aug 2026, 20:51 UTC

Neogenomics Inc's shares are higher in after-market hours, moving significantly above their 20-day moving average and near the upper end of their one-month range.

27 aug 2026, 23:01 UTC

Neogenomics Inc. shares are higher in after-market trading, reflecting notable strength following Thursday's close. The stock remains above its 20-day moving average.

26 aug 2026, 23:01 UTC

News

Neogenomics Inc secures expanded Medicare coverage for RaDaR ST assay, enhancing immunotherapy monitoring. Shares are trading higher in after-market hours.

25 aug 2026, 23:02 UTC

Neogenomics Inc is trading higher in after-market hours, remaining near the upper end of its one-month range and above its 20-day moving average.

24 aug 2026, 23:06 UTC

Neogenomics Inc shares are lower in after-market trading, with no specific news identified. Broader market concerns include the U.S.-Iran conflict and oil supply disruptions.

21 aug 2026, 20:06 UTC

Neogenomics shares are higher, benefiting from a strong trend in the Health Care Services sub-sector, despite no specific company news identified.

20 aug 2026, 21:26 UTC

Neogenomics Inc's shares are higher in after-market trading, maintaining a stable performance since Thursday's close amid no specific news or developments.

19 aug 2026, 19:26 UTC

Neogenomics Inc shares are higher today amid strong buying interest. The stock is approaching the upper end of its one-month trading range.

18 aug 2026, 19:36 UTC

Neogenomics Inc shares are lower today amid broader economic concerns, including rising treasury yields and inflation pressures. The stock reached a session low earlier.

17 aug 2026, 22:01 UTC

Neogenomics Inc is rising in after-market trading, reflecting a strong performance following Monday's close amid a generally positive trading environment and heightened volatility.

14 aug 2026, 23:01 UTC

Neogenomics Inc shares are lower in after-market hours, following a decline influenced by mixed market sentiment and a drop in U.S. retail sales.

13 aug 2026, 22:02 UTC

Neogenomics Inc. shares fell in after-market trading, declining since Thursday's close, despite broader market averages closing higher earlier in the day.

12 aug 2026, 23:51 UTC

Neogenomics Inc shares are higher in after-market trading, maintaining a strong upward trajectory since Wednesday's close, despite no specific news identified.

11 aug 2026, 19:26 UTC

Neogenomics Inc. shares are lower today, with no specific news identified. Investors await U.S. inflation reports that may impact market sentiment.

10 aug 2026, 22:26 UTC

Neogenomics Inc shares are higher in after-market trading, remaining above their 20-day moving average despite no specific news. Rising Treasury yields may influence sentiment.

7 aug 2026, 20:03 UTC

Neogenomics Inc shares are higher during Friday's session, reflecting strong market performance. The stock has advanced since Thursday's close, despite a recent pullback.

6 aug 2026, 21:51 UTC

Neogenomics Inc shares are higher in after-market trading, reaching a notable high and remaining above their 20-day moving average. No specific news was identified.

Peer Vergelijking

Prijswijziging

NeoGenomics Inc Prognose

Koersdoel

By TipRanks

-2.95% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 18.333 USD  -2.95%

Hoogste 21 USD

Laagste 16 USD

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor NeoGenomics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

8 ratings

5

Buy

3

Hold

0

Sell

Sentiment

By Acuity

310 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.